Airdate: Thursday, October 28, 2021 Season: 8 Episode: 59
Guests: Joanna Hummer, Florie Le Prieult
This episode of #ExpertAnswers features Joanna Hummer, Deputy Head of Biomedical Tissue Monitoring at Joanneum Research Health and Florie Le Prieult, Lab Head of In Vivo Neuroscience Pharmacokinetics at Abbvie. They are here to discuss cerebral open flow microperfusions use, and honing in specifically on its use in drug development and neurodegenerative disease.
For more information or to watch the webinar, click here.
Associated Webinar: Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling – Comparison of cOFM and Microdialysis
Similar Podcasts
Talking Real Science with Meaghan Loy on Rare Disease Day
On this episode of #ShareScience, we spoke with Meaghan Loy, Senior Category Director of In Vivo Services with Scientist.com, on Rare Disease Day.
#ExpertAnswers: Conor McCartin on Phage Display Technologies
Dr. Conor McCartin from ProteoGenix answers questions about the utilization of phage display in the development of human antibodies.
#ExpertAnswers: Victor Arrieta on Anti-PD-1 Immunotherapy for Recurrent Glioblastoma
Dr. Víctor Andrés Arrieta explores how p-ERK activation links to better survival in rGBM patients treated with anti-PD-1 immunotherapy.
Related Content
The Translational Utility of Ultrasound and Photoacoustics in Head and Neck Oncology
Dr. Mukund Seshadri presents his interdisciplinary research on developing and evaluating ultrasound and photoacoustic imaging for oral oncology applications, with a focus on the prognostic utility of these methods in assessing treatment responses in head and neck cancer patients.
Unraveling European Animal Welfare Legislation for Biotech & Pharma
This event illuminates the intricacies of animal welfare legislation, specifically comparing and distinguishing differences between EU, UK, and North American standards.
Understanding Animal Welfare Best Practices in Asia Pacific for Biotech & Pharma
In this event, we focus on the Asia Pacific region, uncovering the landscape of animal welfare legislation and its implications for pharmaceutical and biotech players.